Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-06-04 | 2021-08-13 | 140439 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-09 | 2021-08-16 | 142275 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2021-08-03 | 2021-08-16 | 143404 |
APO-AMLODIPINE | 10MG | TABLET | Resolved | 2021-07-23 | 2021-08-23 | 142970 |
APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
APO-SILDENAFIL | 50MG | TABLET | Resolved | 2021-06-04 | 2021-08-23 | 140434 |
APO-QUETIAPINE | 200MG | TABLET | Resolved | 2021-06-25 | 2021-08-25 | 141543 |
APO-QUETIAPINE | 100MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140785 |
APO-QUETIAPINE | 200MG | TABLET | Actual shortage | 2021-06-11 | 2021-08-27 | 140788 |
APO-QUETIAPINE | 25MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144776 |
APO-QUETIAPINE | 300MG | TABLET | Actual shortage | 2021-08-27 | 2021-08-27 | 144779 |
APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2021-07-05 | 2021-08-30 | 141857 |
APO-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2021-06-25 | 2021-08-31 | 141518 |
APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-06-11 | 2021-08-31 | 140775 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-07-16 | 2021-08-31 | 142674 |
APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-07-23 | 2021-08-31 | 142979 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2021-07-16 | 2021-09-01 | 142680 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 |